|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000872,
umls-concept:C0004348,
umls-concept:C0017480,
umls-concept:C0040732,
umls-concept:C0205099,
umls-concept:C0205179,
umls-concept:C0239307,
umls-concept:C0332835,
umls-concept:C0376691,
umls-concept:C0439859,
umls-concept:C0553580,
umls-concept:C1014208,
umls-concept:C1515895,
umls-concept:C1517942,
umls-concept:C1519814,
umls-concept:C2603343
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2001-1-4
|
|
pubmed:abstractText |
An update of results from the High Risk Protocol of the Meta-EICESS Study, conducted at the Pediatric Stem-Cell Transplant Centers of Düsseldorf and Vienna. In order to evaluate a possible therapeutic benefit after allogeneic SCT in patients with advanced Ewing tumors (AET), we compared outcome after autologous and allogeneic stem-cell transplantation (SCT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:AhrensSS,
pubmed-author:BurdachSS,
pubmed-author:DirksenUU,
pubmed-author:DunstJJ,
pubmed-author:EngelBB,
pubmed-author:GadnerHH,
pubmed-author:Go elUU,
pubmed-author:HaaseRR,
pubmed-author:HeyllAA,
pubmed-author:JürgensHH,
pubmed-author:KörholzDD,
pubmed-author:KahnTT,
pubmed-author:KrammCC,
pubmed-author:LadensteinRR,
pubmed-author:LawsH JHJ,
pubmed-author:NürnbergerWW,
pubmed-author:PapeHH,
pubmed-author:WillersRR,
pubmed-author:van KaichGG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1451-62
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11142486-Adolescent,
pubmed-meshheading:11142486-Adult,
pubmed-meshheading:11142486-Age Factors,
pubmed-meshheading:11142486-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11142486-Bone Neoplasms,
pubmed-meshheading:11142486-Case Management,
pubmed-meshheading:11142486-Cause of Death,
pubmed-meshheading:11142486-Child,
pubmed-meshheading:11142486-Combined Modality Therapy,
pubmed-meshheading:11142486-Disease-Free Survival,
pubmed-meshheading:11142486-Dose Fractionation,
pubmed-meshheading:11142486-Female,
pubmed-meshheading:11142486-Follow-Up Studies,
pubmed-meshheading:11142486-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11142486-Humans,
pubmed-meshheading:11142486-Immunologic Factors,
pubmed-meshheading:11142486-Interleukin-2,
pubmed-meshheading:11142486-Male,
pubmed-meshheading:11142486-Myelodysplastic Syndromes,
pubmed-meshheading:11142486-Neoplasm Metastasis,
pubmed-meshheading:11142486-Neoplasms, Second Primary,
pubmed-meshheading:11142486-Prognosis,
pubmed-meshheading:11142486-Radiotherapy, Adjuvant,
pubmed-meshheading:11142486-Remission Induction,
pubmed-meshheading:11142486-Risk Factors,
pubmed-meshheading:11142486-Sarcoma, Ewing,
pubmed-meshheading:11142486-Survival Analysis,
pubmed-meshheading:11142486-Transplantation, Autologous,
pubmed-meshheading:11142486-Transplantation, Homologous,
pubmed-meshheading:11142486-Transplantation Conditioning,
pubmed-meshheading:11142486-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
|
|
pubmed:affiliation |
Division of Pediatric Hematology/Oncology, Children' s Hospital Medical Center, Martin Luther University Halle-Wittenberg, Halle, Germany. stefan.burdach@medizin.uni-halle.de
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
